rxstat › Shortages › Paroxetine

Paroxetine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Paroxetine products are in shortage in Canada (2 of 33 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 18, 2026.
Products affected
2 / 33
In shortage since
Feb 4, 2026
Est. full return
Dec 18, 2026
Reports on file
102
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PAXIL TAB 20MG
20MG · TABLET · GLAXOSMITHKLINE INC
DIN 01940481 · since Apr 30, 2026, est. end Dec 18, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-PAROXETINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 02248558 · since Feb 4, 2026, no end estimate · Disruption of the manufacture of the drug.
Anticipated
PAXIL CR
12.5MG · TABLET (EXTENDED-RELEASE) · GLAXOSMITHKLINE INC
DIN 02248503 · Disruption of the manufacture of the drug.
Resolved
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556 · ended Jun 16, 2026 · Disruption of the manufacture of the drug.
Discontinued
PAXIL TAB 30MG
30MG · TABLET · GLAXOSMITHKLINE INC
DIN 01940473
reversed
TEVA-PAROXETINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02248557
reversed
TEVA-PAROXETINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02248557
reversed
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556
Discontinued
PAXIL TAB 10MG
10MG · TABLET · GLAXOSMITHKLINE INC
DIN 02027887
Resolved
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556 · ended Mar 19, 2025 · Shortage of an inactive ingredient or component.
Discontinued
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556
Discontinued
TEVA-PAROXETINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02248557

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Paroxetine is currently affected by 2 active shortage reports filed with Health Canada by GLAXOSMITHKLINE INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Paroxetine is classified under “ANTIDEPRESSANTS” (ATC N06AB).

Recent changes

Common questions

When will Paroxetine be back in stock in Canada?

The latest manufacturer estimate is Dec 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Paroxetine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antidepressants)

Widespread shortageClomipramine3 of 4 reported products affected · est. return Jul 3, 2026Widespread shortageImipramine3 of 6 reported products affected · est. return Aug 28, 2026Partial shortageAmitriptyline15 of 34 reported products affected · est. return Jul 17, 2026Partial shortageBupropion3 of 15 reported products affected · est. return Jul 15, 2026Partial shortageCitalopram10 of 43 reported products affected · est. return Sep 30, 2026Partial shortageDesvenlafaxine2 of 17 reported products affected · est. return Jul 31, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.